2020 DGHO指南:恶性血液病和实体肿瘤患者细菌感染以及肺孢子虫肺炎的一级预防

2021-04-13 国外血液科相关专家小组 Ann Hematol . 2021 Apr 13.

2021年4月,德国血液学和肿瘤学学会(DGHO)感染性疾病工作组发布了恶性血液病和实体肿瘤患者细菌感染以及肺孢子虫肺炎的一级预防指南,恶性血液病和实体肿瘤患者化疗或免疫治疗相关的免疫抑制存在很大的细

中文标题:

2020 DGHO指南:恶性血液病和实体肿瘤患者细菌感染以及肺孢子虫肺炎的一级预防

英文标题:

Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematolog

发布日期:

2021-04-13

简要介绍:

2021年4月,德国血液学和肿瘤学学会(DGHO)感染性疾病工作组发布了恶性血液病和实体肿瘤患者细菌感染以及肺孢子虫肺炎的一级预防指南,恶性血液病和实体肿瘤患者化疗或免疫治疗相关的免疫抑制存在很大的细菌感染和肺孢子虫肺炎的风险。本文主要针对上述患者的这些感染的一级预防提供指导建议。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=恶性血液病和实体肿瘤患者细菌感染以及肺孢子虫肺炎.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9b8041c0020855d9, title=2020 DGHO指南:恶性血液病和实体肿瘤患者细菌感染以及肺孢子虫肺炎的一级预防, enTitle=Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematolog, guiderFrom=Ann Hematol . 2021 Apr 13., authorId=0, author=, summary=2021年4月,德国血液学和肿瘤学学会(DGHO)感染性疾病工作组发布了恶性血液病和实体肿瘤患者细菌感染以及肺孢子虫肺炎的一级预防指南,恶性血液病和实体肿瘤患者化疗或免疫治疗相关的免疫抑制存在很大的细, cover=https://img.medsci.cn/2021423/1619188031507_2020535.jpg, journalId=0, articlesId=null, associationId=971, associationName=国外血液科相关专家小组, associationIntro=null, copyright=0, guiderPublishedTime=Tue Apr 13 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年4月,德国血液学和肿瘤学学会(DGHO)感染性疾病工作组发布了恶性血液病和实体肿瘤患者细菌感染以及肺孢子虫肺炎的一级预防指南,恶性血液病和实体肿瘤患者化疗或免疫治疗相关的免疫抑制存在很大的细菌感染和肺孢子虫肺炎的风险。本文主要针对上述患者的这些感染的一级预防提供指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=43020, tagName=恶性血液病)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=43020, guiderKeyword=恶性血液病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=19640, appHits=119, showAppHits=0, pcHits=624, showPcHits=19520, likes=1, shares=8, comments=7, approvalStatus=1, publishedTime=Fri Apr 23 23:07:59 CST 2021, publishedTimeString=2021-04-13, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Fri Apr 23 22:27:21 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 09:42:44 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=恶性血液病和实体肿瘤患者细菌感染以及肺孢子虫肺炎.pdf)])
恶性血液病和实体肿瘤患者细菌感染以及肺孢子虫肺炎.pdf
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1063909, encodeId=525c106390926, content=想学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96015548079, createdName=ms9000001629140354, createdTime=Mon Oct 25 22:48:51 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011840, encodeId=752d101184025, content=很好的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffe2532351, createdName=12504519m26暂无昵称, createdTime=Thu Aug 26 22:05:41 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960044, encodeId=708e96004480, content=很好的指南,支持了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61c55485792, createdName=ms8000001091738002, createdTime=Sat Apr 24 16:23:55 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966120, encodeId=c107966120de, content=看看啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40492097670, createdName=路是什么样的路, createdTime=Sun May 16 23:31:56 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960632, encodeId=350596063211, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Apr 26 15:05:18 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2021-10-25 ms9000001629140354

    想学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1063909, encodeId=525c106390926, content=想学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96015548079, createdName=ms9000001629140354, createdTime=Mon Oct 25 22:48:51 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011840, encodeId=752d101184025, content=很好的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffe2532351, createdName=12504519m26暂无昵称, createdTime=Thu Aug 26 22:05:41 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960044, encodeId=708e96004480, content=很好的指南,支持了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61c55485792, createdName=ms8000001091738002, createdTime=Sat Apr 24 16:23:55 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966120, encodeId=c107966120de, content=看看啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40492097670, createdName=路是什么样的路, createdTime=Sun May 16 23:31:56 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960632, encodeId=350596063211, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Apr 26 15:05:18 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2021-08-26 12504519m26暂无昵称

    很好的指南

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1063909, encodeId=525c106390926, content=想学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96015548079, createdName=ms9000001629140354, createdTime=Mon Oct 25 22:48:51 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011840, encodeId=752d101184025, content=很好的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffe2532351, createdName=12504519m26暂无昵称, createdTime=Thu Aug 26 22:05:41 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960044, encodeId=708e96004480, content=很好的指南,支持了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61c55485792, createdName=ms8000001091738002, createdTime=Sat Apr 24 16:23:55 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966120, encodeId=c107966120de, content=看看啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40492097670, createdName=路是什么样的路, createdTime=Sun May 16 23:31:56 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960632, encodeId=350596063211, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Apr 26 15:05:18 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2021-04-24 ms8000001091738002

    很好的指南,支持了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1063909, encodeId=525c106390926, content=想学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96015548079, createdName=ms9000001629140354, createdTime=Mon Oct 25 22:48:51 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011840, encodeId=752d101184025, content=很好的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffe2532351, createdName=12504519m26暂无昵称, createdTime=Thu Aug 26 22:05:41 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960044, encodeId=708e96004480, content=很好的指南,支持了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61c55485792, createdName=ms8000001091738002, createdTime=Sat Apr 24 16:23:55 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966120, encodeId=c107966120de, content=看看啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40492097670, createdName=路是什么样的路, createdTime=Sun May 16 23:31:56 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960632, encodeId=350596063211, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Apr 26 15:05:18 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2021-05-16 路是什么样的路

    看看啊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1063909, encodeId=525c106390926, content=想学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96015548079, createdName=ms9000001629140354, createdTime=Mon Oct 25 22:48:51 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011840, encodeId=752d101184025, content=很好的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dffe2532351, createdName=12504519m26暂无昵称, createdTime=Thu Aug 26 22:05:41 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960044, encodeId=708e96004480, content=很好的指南,支持了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61c55485792, createdName=ms8000001091738002, createdTime=Sat Apr 24 16:23:55 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966120, encodeId=c107966120de, content=看看啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40492097670, createdName=路是什么样的路, createdTime=Sun May 16 23:31:56 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960632, encodeId=350596063211, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Apr 26 15:05:18 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2021-04-26 jyzxjiangqin

    好文章!

    1

    展开1条回复